China pharma holdings, inc. announced the acquisition of dry eye disease therapeutic device project
Haikou, china , dec. 5, 2022 /prnewswire/ -- china pharma holdings, inc. (nyse american: cphi) ("china pharma", the "company" or "we"), an nyse american-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in china, today announced the acquisition of dry eye disease therapeutic device project. this device has a patent epidemiological research shows that the incidence rate of ded is about 25% to 30%, and the incidence rate of people over 65-year-old is 75% in china according to the research report on the market status of the global dry eye disease drug industry in 2022 (1), the market size of ded drugs in china in 2021 was approximately rmb3.85 billion (approximately us$0.55 billion), resulting a 12.4% year-on-year growth in the field of ded and visual fatigue, this product will fill in the market gap of medical therapeutic apparatus we have established sales channels in more than 30 provincial and municipal hospitals, as well as otc markets in china for more than 20 years; which will strongly support the launch and promotion of this device dry eye disease (ded) refers to the general term of a variety of diseases related to abnormal tear quality, quantity, or dynamics, accompanied by eye discomfort (dry eyes, tingling, burning, gritty feeling, etc.
CPHI Ratings Summary
CPHI Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission